While advances have been made in treating lung cancer and risk reduction, there is still plenty of work to be done.
by Bradley Jones
July 17, 2020
Illustration by Happy_vector / iStock / Getty Images Plus
ALTHOUGH LUNG CANCER INCIDENCE AND MORTALITY RATES have decreased in recent decades, the disease remains the second-most common cancer diagnosis in the U.S.
Cancer Today magazine is free to cancer patients, survivors and caregivers who live in the U.S. Subscribe here to receive four issues per year.
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
Financial Screenings for People with CancerCancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
Aggressive Approach to Very Advanced Cancer Does Not Extend SurvivalStudy shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose
A grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
New cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Alexis Browning
